| Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R) (NCT06291103) | University Hospital, Rouen | 2026-07-01 |
| Effect of Opioid-Sparing Anesthesia on Postoperative Opioid Consumption and Pain in Elderly Patients Undergoing Spine Surgery (NCT07588802) | Massachusetts General Hospital | 2026-07-01 |
| To Evaluate the Safety and Efficacy of RP902 Tablets (NCT07579884) | Risen (Suzhou) Pharma Tech Co., Ltd. | 2026-07-01 |
| A Study of FG-B901 Monotherapy or Combination With Chemotherapy in Advanced or Metastatic Solid Tumors (NCT07623707) | FutureGen Biopharmaceutical (Beijing) Co., Ltd | 2026-07-01 |
| A Study of IMM0306 in IgG4-Related Disease (NCT07621939) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2026-07-01 |
| Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France (NCT07729852) | Alterity Therapeutics | 2026-07-01 |
| Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH) (NCT07441200) | NS Pharma, Inc. | 2026-07-01 |
| Combination Immunotherapy Targeting Sarcomas (NCT04433221) | Shenzhen Geno-Immune Medical Institute | 2026-07-01 |
| Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya (NCT07545746) | UNC Lineberger Comprehensive Cancer Center | 2026-07-01 |
| SONATA LIFU for OCD (NCT07728994) | University of Pennsylvania | 2026-07-01 |
| Efficacy and Safety of Paclitaxel Polymeric Micelles in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (NCT07662746) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2026-07-01 |
| A Trial for the Treatment of Advanced Large-Cell Neuroendocrine Cancer of the Lung (NCT07561645) | Technische Universität Dresden | 2026-07-01 |
| Camrelizumab With Famitinib for Patients With Rare Head and Neck Malignancies (NCT07662681) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2026-07-01 |
| MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma (NCT07029776) | University of Arkansas | 2026-07-01 |
| A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for the Prevention of Postoperative Nausea and Vomiting (NCT07709897) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2026-07-01 |
| Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART) (NCT07011589) | M. Peter Marinkovich | 2026-07-01 |
| Oral Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis (NCT05202990) | Assistance Publique - Hôpitaux de Paris | 2026-07-01 |
| Triple-Blind Randomized Clinical Trial of Tocilizumab vs Placebo: Potential Use of an IL-6 Antagonist as an Adjuvant to Standard Treatment for Treatment-Resistant Major Depression in the Brazilian Public Health System (SUS) (NCT07052058) | Hospital de Clinicas de Porto Alegre | 2026-07-01 |
| A Study of Metformin to Improve Cardiac Function After LVAD Implantation (NCT07666698) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2026-07-01 |
| Selinexor Monotherapy for Cytoreduction in BCR::ABL1-Negative Myeloproliferative Neoplasms (NCT07626021) | Zhongshan Hospital (Xiamen), Fudan University | 2026-07-01 |
| Perioperative Dexmedetomidine to Reduce Post-procedure Grief Following Second-trimester Dilation and Evacuation (NCT07537894) | Stanford University | 2026-07-01 |
| Neoadjuvant EGFR-ADC Combined With Anti-PD-1 Monoclonal Antibody in Resectable Locally Advanced Hypopharyngeal Squamous Cell Carcinoma (NCT07665190) | Tianjin Medical University Cancer Institute and Hospital | 2026-07-01 |
| A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension. (NCT07708441) | Shandong Suncadia Medicine Co., Ltd. | 2026-07-01 |
| Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation (NCT06214403) | University Health Network, Toronto | 2026-07-01 |
| A Phase II Exploratory Study of SR604 Injection Evaluating the Safety and Efficacy in the Treatment of Congenital Coagulation Factor VII Deficiency (NCT07711158) | Shanghai RAAS Blood Products Co., Ltd. | 2026-07-01 |
| Study of Protection And Repair of Endothelial-glycocalyx in Sepsis (SPARES) (NCT07160426) | Beth Israel Deaconess Medical Center | 2026-07-01 |
| A Prospective Clinical Study on Reduced-intensity Radiotherapy for Stage I/II Low-risk Nasal-type NK/T-cell Lymphoma Achieving Complete Remission After Chemotherapy (NCT07628738) | Ruijin Hospital | 2026-07-01 |
| Safety and Immunogenicity Study of IP-QSV Vaccine in Healthy Adults/Adolescents, Children and Infants (NCT07666750) | International Vaccine Institute | 2026-07-01 |
| A 24-Week Real-World Study of Upadacitinib in Moderate-to-Severe Hidradenitis Suppurativa (NCT07727889) | Peking Union Medical College | 2026-07-01 |
| Rituximab Maintenance Versus Observation After R2 Induction in Previously Untreated Marginal Zone Lymphoma (NCT07654465) | Sun Yat-sen University | 2026-07-01 |
| Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical Prostatectomy (NCT07711314) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2026-07-01 |
| Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH) (NCT07601295) | Stanford University | 2026-07-01 |
| KORTUC (KRC-01) Plus Radiotherapy for Organ Preservation in Rectal Cancer (NCT07622017) | Gustave Roussy, Cancer Campus, Grand Paris | 2026-07-01 |
| Effects of a Sigle Dose of Ayahuasca in Patients With Psychogenic Non-epileptic Seizures: an Open Label Clinical Trial (NCT07747324) | University of Sao Paulo | 2026-07-01 |
| PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure (NCT07619898) | Therakos LLC | 2026-07-01 |
| Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex (NCT07431307) | BioVersys AG | 2026-07-01 |
| Zanidatamab Combined With Chemotherapy as Neoadjuvant/Conversion Therapy for HER2-Positive (IHC 3+ or IHC 2+) Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Phase II Open-Label Study (NCT07685704) | Zhifeng Zhao, PhD | 2026-07-01 |
| HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer (NCT07621484) | Shanghai Changzheng Hospital | 2026-07-01 |
| A Pilot Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants With Post-Stroke Spasticity (The STIPS Study) (NCT07704840) | Alberto Esquenazi | 2026-07-01 |
| A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL (NCT06979076) | MingSight Pharmaceuticals, Inc | 2026-07-01 |
| Phase I-II PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT (NCT07675174) | Northwell Health | 2026-07-01 |
| Intermittent Low Oxygen Breathing: A First Study Testing Different Disease Stages in People Living With MS (NCT07631143) | University of Saskatchewan | 2026-07-01 |
| Evaluation of the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder (NCT06651541) | Biozeus Biopharmaceutical S.A. | 2026-07-01 |
| SIRIUS - Initial Combination Therapy With an Endothelin Receptor Antagonist, a Phosphodiesterase-5 Inhibitor and Sotatercept in Patients With Newly Diagnosed Pulmonary Arterial Hypertension (NCT07266519) | Philipps University Marburg | 2026-07-01 |
| Investigating the Clinical Benefits and Underlying Mechanisms of Danhong Injection in Modulating Mitochondrial Homeostasis Against Sepsis-Associated Myocardial Dysfunction (NCT07375862) | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 2026-07-01 |
| Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation (NCT06348147) | UNC Lineberger Comprehensive Cancer Center | 2026-07-01 |
| TNT With FLOT/Durvalumab Plus Post-OP Durvalumab for Resectable Gastroesophageal Adenocarcinoma (NCT07507968) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2026-07-01 |
| Zanzalintinib in Men With Aggressive Variant Prostate Cancer (NCT07218666) | Deepak Kilari | 2026-07-01 |
| Mechanisms of Cannabidiol and Sleep in the Context of Alcohol Use (NCT07527338) | University of Colorado, Boulder | 2026-07-01 |
| Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma (NCT07527325) | University of California, Irvine | 2026-07-01 |
| Synthetic THC And Blood Pressure (NCT07231965) | Mayo Clinic | 2026-07-01 |
| Safety and Efficacy of AIV007 Periocular Injection in Patients With Neovascular Age-Related Macular Degeneration (NCT07557121) | AiViva BioPharma, Inc. | 2026-07-01 |
| Melatonin for the Treatment of DEE-SWAS (NCT07221968) | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 2026-07-01 |
| New Genotype-guided Treatment in Newly Diagnosed PTCL (NCT07706959) | Ruijin Hospital | 2026-07-01 |
| Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults (NCT07575438) | May Faraj, PDt, PhD | 2026-07-01 |
| A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma (NCT06855225) | Mehmet Akce | 2026-07-01 |
| DaxibotulinumtoxinA for Blepharospasm (NCT07489430) | University of Pennsylvania | 2026-07-01 |
| Belumosudil With Ruxolitnib as Second Line Therapy for Chronic Graft Versus Host Disease (cGvHD) After Steroid Failure (NCT07643025) | Dennis Kim | 2026-07-01 |
| A Phase Ib/II Study of BM230 in Combination With PD-1 Inhibitor for HER2-related Advanced Solid Tumors (NCT07698587) | Suzhou Biomissile Pharmaceuticals Co., Ltd. | 2026-07-01 |
| The Effects of Timolol On Healing and Cosmesis of Mohs Scalp Wounds: An Open Label Trial (NCT07583862) | Geisinger Clinic | 2026-07-01 |
| Post-Operative Steroids After Sleep Surgery (NCT06818981) | Medical University of South Carolina | 2026-07-01 |
| Comparing Intravenous or Intradermal Administration of Anti-CTLA-4 in Combination With Anti-PD1 Treatment in Patients With Melanoma (NCT07615881) | Amsterdam UMC, location VUmc | 2026-07-01 |
| CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD) (NCT07576699) | Cellenkos, Inc. | 2026-07-01 |
| Yeast Protein for Muscle Mass (NCT07561619) | University of Alberta | 2026-07-01 |
| Comparative ¹⁸F-FDG and ⁶⁸Ga-MY6349 PET/CT Imaging for Assessing TROP2 ADC Therapeutic Efficacy in EGFR-TKI Resistant Advanced NSCLC (NCT07685197) | Zhou Chengzhi | 2026-07-01 |
| Bepirovirsen Liver Biopsy Study (NCT07696520) | National University Health System, Singapore | 2026-07-01 |
| EVERolimus and LenvAtinib Versus Everolimus for Bone Sarcoma (NCT07619950) | Yonsei University | 2026-07-01 |
| Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems (NCT07616206) | vTv Therapeutics | 2026-07-01 |
| A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma (NCT07632235) | Shanghai 6th People's Hospital | 2026-07-01 |
| Immunotherapy Master Trial for Advanced Cancers (NCT07431073) | UNICANCER | 2026-07-01 |
| A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer (NCT03301805) | Rgene Corporation | 2026-07-01 |
| "Exploring the Potential Benefits of Using Dapagliflozin in Cirrhotic Chronic Liver Disease Patients- A Randomized Controlled Trial" (NCT07684326) | Beni-Suef University | 2026-07-01 |
| A Clinical Trial of HRS-3095 in Patients With Chronic Spontaneous Urticaria (NCT07613866) | Chengdu Suncadia Medicine Co., Ltd. | 2026-07-01 |
| Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity (NCT07572175) | Icahn School of Medicine at Mount Sinai | 2026-07-01 |
| A Reduced Dose of Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy Loss (NCT06909123) | Stanford University | 2026-07-01 |
| Functional Brain MRI to Understand Pain Phenotypes in Knee Osteoarthritis (NCT07668674) | University Hospital, Clermont-Ferrand | 2026-07-01 |
| Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner Syndrome (NCT05847179) | PRG Science & Technology Co., Ltd. | 2026-07-01 |
| The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma (NCT07565285) | Primmune Therapeutics, Inc. | 2026-07-01 |
| Stimulation-based Therapy to Improve Balance in DCM (NCT07298460) | Medical College of Wisconsin | 2026-07-01 |
| Lisaftoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients (NCT07597941) | The Affiliated People's Hospital of Ningbo University | 2026-07-01 |
| Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax (NCT07471841) | Timothy Pardee | 2026-07-01 |
| Evaluation of the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis (NCT07668895) | Peking Union Medical College Hospital | 2026-07-01 |
| Clinical Trials to Evaluate Metformin to Treat Depression in People Living With HIV (NCT07007221) | University of Minnesota | 2026-07-01 |
| A Study to Evaluate the Efficacy and Safety of HRS-4729 Injection in Obesity (NCT07690826) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2026-07-01 |
| De-Escalation of Axillary Management in Advanced Nodal Disease (NCT07643584) | University of Kansas Medical Center | 2026-07-01 |
| Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (NCT07220252) | TG Therapeutics, Inc. | 2026-07-01 |
| A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular Carcinoma (NCT07682272) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2026-07-01 |
| Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome (NCT07257978) | Fenix Innovation Group | 2026-07-01 |
| Ketones for Opioid Craving (NCT07128524) | University of Maryland, Baltimore | 2026-07-01 |
| Preoperative Radiotherapy and Anlotinib With or Without Penpulimab for Soft Tissue Sarcoma (NCT07612098) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-07-01 |
| A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS (NCT06906471) | Antelope Surgical Solutions, Inc | 2026-07-01 |
| Psilocybin Efficacy With or Without Pimavanserin Pretreatment (NCT07610135) | Johns Hopkins University | 2026-07-01 |
| A Clinical Study to Evaluate the Efficacy and Safety of VG2025 in Intrahepatic Cholangiocarcinoma (NCT07522476) | Virogin Biotech Ltd. | 2026-07-01 |
| Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas (NCT06476704) | Centre Paul Strauss | 2026-07-01 |
| Hexaminolevulinate Photodynamic Therapy (HAL-PDT) With Deferred Surgery Versus Surgery for High-grade Squamous Intraepithelial Lesions (HSIL) (NCT07669363) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2026-07-01 |
| Acute Effects of Cannabis on Cognition and Affect (NCT07296874) | Washington State University | 2026-07-01 |
| Topical Carboxytherapy Paste Following Microneedling (NCT07431541) | Vanderbilt University Medical Center | 2026-07-01 |
| A Study on the Efficacy and Safety of Sintilimab Combined With Ramucirumab and Paclitaxel in the Treatment of Gastric Cancer Patients With Short-term Recurrence After Adjuvant Therapy (NCT07669740) | The First Affiliated Hospital with Nanjing Medical University | 2026-07-01 |
| CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa) (NCT07153289) | University Hospital Tuebingen | 2026-07-01 |
| Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss. (NCT07411378) | Biophytis | 2026-07-01 |